Impact of Letermovir on Voriconazole Concentrations in Lung Transplant Patients. (PubMed, Transpl Infect Dis) - Aug 17, 2026 - "This is the first study evaluating the impact of concomitant letermovir on voriconazole exposure during the early posttransplant period in lung transplant recipients. Concomitant letermovir was associated with reduced attainment of target voriconazole concentrations, supporting routine therapeutic drug monitoring and consideration of empiric voriconazole dose escalation when these agents are co-administered."
Journal • Cytomegalovirus Infection • Infectious Disease • Transplantation
|
|
Erin K McCreary; Fernanda Silveira; Leah Georgiades; Raman Venkataramanan; Ryan M Rivosecchi; Sunish Shah; Vignesh Vasudevan
|